Risperidone (Risperdal) News, Updated Regularly

Second-Generation Antipsychotics Not All Superior to Older Drugs - Medscape News
January 2, 2009, 11:26 am

January 2, 2009 ? A meta-analysis finds that only 4 of 9 second-generation antipsychotics were more efficacious than first-generation antipsychotics for schizophrenia, with small to medium effect sizes. In addition, the classification system of ...

Police, shelter reach out to troubled homeless people - AZCentral.com
January 5, 2009, 4:13 am

Cecilia didn't look up. A man who was with her had slinked away into the darkness, leaving a broken crack pipe and Cecilia alone to answer police and social workers. She rummaged through a tote filled with papers and other clutter, ignoring the ...

Harvard Psychiatrist Biederman Stops Industry-Funded Work Amid Probe - Wall Street Journal
December 31, 2008, 5:30 am

Controversial Harvard psychiatrist Joseph Biederman has agreed to stop working on clinical trials funded by industry until Massachusetts General Hospital finishes looking into allegations that he didn?t adequately report the funding he has received ...

Are you looking for additional Risperdal (Risperidone) news? Try our new "Risperidone News Focus" area.

Are you looking for additional Risperdal (Risperidone) information? Try our new "Risperidone Related Blog Entries" area.

Off-site Risperidone (Risperdal) Links, User Submitted

The following links have been collected through user bookmark submission in the Risperidone_Risperdal category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.

Fri Dec 12

• Second-generat ion versus first-generati on antipsychotic drugs for schizophrenia: a meta-analysis. [2008 Dec 4.]: Four of these drugs were better than first-generati on antipsychotic drugs for overall efficacy, with small to medium effect sizes (amisulpride -0.31 [95% CI -0.44 to -0.19, p<0.0001], clozapine -0.52 [-0.75 to -0.29, p<0.0001], olanzapine -0.28 [-0.38 to -0.18, p<0.0001], and risperidone -0.13 [-0.22 to -0.05, p=0.002]).
• Predictors for Starting Depot Administration of Risperidone in Chronic Users of Antipsychotics .: According to abstract, depo Risperidone users more likely to be male, less med-compliant, and more severely mentally ill than users of oral antipsychotics .

Sat Nov 29

• RISPERDAL
• Risperidone in the Treatment of Autism

Wed Nov 26

• LORETA functional imaging in antipsychotic- naive a...[Neuropsyc hobiology. 2008] - PubMed Result: compared to unmedicated patients, general increases in slow delta and theta over the frontal-tempor al-occipital corticies, particularly in the temporolimbic areas, increases in alpha1 and alpha2 in the temporal cortex, and increases in beta1 and beta2 in the temporo-occipi tal and posterior limbic areas. clozapine patients had increases in delta+theta in the anterior cingulate and medial frontal cortex as well as decreases in alpha1, beta2, and beta3 in the occipital cortex and posterior limbic areas and decreases in alpha1 and beta2 in the occipital lobe. asdf... more medication specific info in the abstract, I'm not re-paraphrasin g all of this crap

Tue Nov 25

• 14 Drugs Most Needing Study For Off-label Use

Fri Sep 26

• Double-Blind Comparison of First- and Second-Generat ion Antipsychotics in Early-Onset Schizophrenia and Schizo-affecti ve Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study. [Am J Psychiatry. 2008 Sep 15.]: Risperidone and olanzapine did not demonstrate superior efficacy over molindone for treating early-onset schizophrenia and schizoaffectiv e disorder. Adverse effects were frequent but differed among medications. The results question the nearly exclusive use of second-generat ion antipsychotics to treat early-onset schizophrenia and schizoaffectiv e disorder. The safety findings related to weight gain and metabolic problems raise important public health concerns, given the widespread use of second-generat ion antipsychotics in youth for nonpsychotic disorders.

Sun Aug 24

• Efficacy of Risperidone Augmentation to Antidepressant s in the Management of Suicidality in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Contro lled Pilot Study: Data from this pilot study suggest that risperidone is beneficial as an augmenting treatment in MDD patients who have developed high-risk suicidal ideation during a depressive episode. The antisuicidalit y effect of risperidone is especially valuable in the acute management of severe depressive symptoms. Although the pilot study is limited by small sample size, the promising results warrant further larger scale investigation in the efficacy of atypical antipsychotics in the treatment of severe depression with suicidality.
• Open-label trial of olanzapine plus risperidone. [Hum Psychopharmaco l. 2008 Aug;23(6):455- 63.]: Antipsychotic polypharmacy might be sometimes helpful for difficult populations but at the cost of adverse effects. More studies of antipsychotic combination therapy versus clozapine, augmentation strategies or tenacious longer- term monotherapy are warranted for refractory schizophrenia.

Wed Aug 6

• Risperdal (Risperidone) drug warnings and precautions - prescription drugs and medications at RxList
• Risperdal side effects (Risperidone) and drug interactions - prescription drugs and medications at RxList
• MedlinePlus Drug Information: Risperidone
• risperidone (Risperdal) - drug class, medical uses, medication side effects, and drug interactions by MedicineNet.co m
• risperidone - Google Search
• Risperdal (Risperidone) drug indications and dosage - prescription drugs and medications at RxList

Off-site Risperidone Research Links

If you still need additional information on Risperidone then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.